Posts

Ivermectin and COVID-19: Why it’s promising

Image
Doctors around the world has been reporting high success rates using an inexpensive anti-parasitic treatment for COVID-19.  In April last year, a trial at Melbourne’s Monash University  reported  doses of ivermectin stopped or slowed the spread of Covid-19 infection in the lab environment. The researchers said the findings could not be immediately applied to humans but the drug still surged in popularity across  Peru, Bolivia, Guatemala and other Latin American countries . Another study  published in June 2020 by Nature , ivermectin was found to have antiviral activity against a range of viruses including Avian influenza A, Porcine Reproductive and Respiratory Syndrome, HIV, and SARS-Cov-2. The medical community is battling over whether ivermectin should be used to treat and prevent COVID-19. On one side are experts telling you that more research is needed before the treatment can be fully authorised. On the other, are experts telling you that the potential benefits outweigh the risk.

10 Best Outpatient Treatments for COVID-19 (updated February 2021)

Image
The COVID-19 Outpatient treatment guidelines are based on the AAPS (American Association of Physicians and Surgeons). The aim of this article is to publish the guidelines in an electronic format that can be updated in step with the rapid pace and growing volume of related information and evidence related to the outpatient treatment of COVID-19. Outpatient treatment administered outside of the hospitalized setting should be under the supervision of a physician or licensed medical professional who is knowledgeable in the use of the medications and the monitoring approach for ambulatory, home-based COVID-19. Patients who worsen in any way should seek emergency room evaluation immediately. This article will focus on early, ambulatory, home-based medical treatment overseen by your physician, using a combination of available medicines, already FDA-approved for other medical conditions, and widely used in clinical medicine every day.  Most doctors know the need to focus now on early treatment

COVID-19 Outpatient Treatment Guidelines - AAPS, FLCCC, Zelenko Treatment Protocols

Image
The COVID-19 Outpatient treatment guidelines are based on various protocols including (but not limited to) AAPS (American Association of Physicians and Surgeons), FLCCC (Front Line Covid-19 Critical Care Alliance) and Dr Vladimir Zelenko . The aim of this article is to publish the guidelines and compile related resources in an electronic format that can be updated in step with the rapid pace and growing volume of related information regarding the outpatient treatment of COVID-19. What's New Feb 9, 2021 -  Ivermectin plus Azithromycin plus Montelukast plus Aspirin totally crush Covid-19 in propective Mexican study (n=768). The TNR4 multidrug therapy (New Therapy for Recovery of COVID-19 infection, 4 medications; in Spanish:  T erapia  N ueva para la  R ecuperación en la infección por COVID19,  4  medicamentos). Lima-Morales R, Mendez-Hernandez P, Flores YN, Osorno-Romero P, Cuecuecha-Rugerio E, Nava-Zamora A, Hernandez-Galdamez DR, Romo-Duenas DK, Salmeron J, Effectiveness of a mul

Ivermectin and COVID-19: Meta Analysis of 36 studies (February 2021)

Image
At-A-Glance: 100% of the 36 studies to date report positive effects. Early treatment is more successful, with an estimated reduction of 82% in the effect measured using a random effects meta-analysis, RR 0.18 [0.10-0.34]. Prophylactic use also shows high effectiveness. 100% of the 18 Randomized Controlled Trials (RCTs) report positive effects, with an estimated reduction of 71%, RR 0.29 [0.17-0.50]. The probability that an ineffective treatment generated results as positive as the 36 studies to date is estimated to be 1 in 69 billion (p = 0.000000000015). Introduction We analyze all significant studies concerning the use of ivermectin for COVID-19. Search methods, inclusion criteria, effect extraction criteria (more serious outcomes have priority), all individual study data, PRISMA answers, and statistical methods are detailed in Appendix 1. We present random effects meta-analysis results for all studies, for studies within each treatment stage, for mortality results only, and for Rand